In this video interview, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, explains how continuous remote monitoring enables earlier detection of patient deterioration and allows care ...

In today's ACT Brief, we explore how wearable data is informing real-world clinical decision-making, a statistical method ...

The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...

In today's ACT Brief, we examine the technology infrastructure gap facing investigator-initiated trials, how transparency and ...

Investigator-initiated trials are uniquely unsuited to a patchwork of Google Drive folders, Excel worksheets, and ...

Investigator-initiated trials operate under the same regulatory and operational requirements as industry-sponsored studies but rely on fragmented, consumer-grade tools, creating a persistent ...

In a recent video interview with Applied Clinical Trials, Mohammed Saeed, MD, PhD, chief medical officer of Solera Health, ...

Vaccine hesitancy is widely recognized as one of the most significant public health problems of the 21 st Century. The World Health Organization (WHO) identifies vaccine hesitancy ...

Analysis from the Tufts Center for the Study of Drug Development suggests that transparency in clinical evidence, community engagement, and more representative clinical trials are key factors ...

In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...

In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, makes the case for generalized pairwise comparisons and ...

At the SCOPE Summit, Tekton Research shares how its physician-led clinical trial network is helping accelerate research in ...